View in EDS HTML Full Text PDF Full Text

Ustekinumab trough concentrations predict clinical remission in perianal fistulizing crohn's disease: a real-world retrospective cohort study.

Saved in:
Bibliographic Details
Title: Ustekinumab trough concentrations predict clinical remission in perianal fistulizing crohn's disease: a real-world retrospective cohort study.
Authors: Liu, Xiaoyu1 (AUTHOR), Yan, Yuehua1 (AUTHOR), Yi, Jiaqin1 (AUTHOR), Luo, Dongmei1 (AUTHOR), Geng, Jun1 (AUTHOR), Huang, Huixian1 (AUTHOR), Wang, Jingjing1 (AUTHOR), Gu, Yunfei1 (AUTHOR), Yang, Bolin1 (AUTHOR), Gong, Yuxia1 (AUTHOR) gongyuxia_gyx@126.com, Wang, Hao1 (AUTHOR) yfy114@njucm.edu.cn
Source: BMC Gastroenterology. 10/10/2025, Vol. 25 Issue 1, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:1471230X
DOI:10.1186/s12876-025-04323-x